Is Zolpidem legal in Saudi Arabia?

Also known as: ambien

Legal status

Zolpidem is a controlled psychotropic substance in Saudi Arabia, placed at Schedule II Category D of the schedules attached to the Law of Combating Narcotics and Psychotropic Substances, Royal Decree M/39 of 1426 AH, in the version of those schedules issued on 4 September 2026. The schedule prints «زولبيديم» under the heading «فئة (د):... المؤثرات العقلية», Category D psychotropic substances. Zolpidem is an imidazopyridine rather than a benzodiazepine, and the Kingdom has placed it in the same category as the benzodiazepines by its own entry rather than by treating it as one. It is one of the most commonly prescribed sleep medicines in the world, and its Category D placement means an ordinary insomnia prescription is a controlled substance on arrival. M/39 Articles 1 and 70 to 71 are cited for identification and for keeping the attached schedules current.

Consequences if caught

Article 37(I) reaches a Schedule II Category D substance, and it states no quantity at all. The penalty articles do not sort by category letter or by how ordinary the medicine is: the conduct named is smuggling, receipt from a smuggler, and import, export, manufacture, production, extraction or cultivation with intent to promote, together with the repeat promotion histories the article sets out, with no weight threshold anywhere in it. Death under Article 37(I) is a statutory ta'zir penalty and it is not mandatory, because Article 37(II) gives the court the power to reduce it; where the court does reduce, the substitute is a prison term of not less than fifteen years with the lashes and the fine the article states. No express life imprisonment wording was found anywhere in M/39. Articles 38 to 41 are cited as the tiers below Article 37, and a traveller with a strip of sleeping tablets and no clearance belongs in that lower band rather than in the capital article.

If prescribed or medical

The Saudi traveller rule is a permit rule rather than a prescription rule, and a sleep medicine taken for a long haul flight is exactly the case people forget to arrange. A controlled medicine may be brought in only under a clearance obtained from the SFDA before travel through its Controlled Drugs System, and that advance electronic clearance is required rather than optional. A prescription written abroad is not a Saudi clearance and does not become one on arrival. Zolpidem sits inside that regime as a Schedule II Category D substance, so the clearance question governs it.

Documentation

Apply through the SFDA Controlled Drugs System before travelling rather than on arrival, and carry the clearance itself and not the prescription alone. Bring the medicine in its original dispensing packaging with the prescription and a medical report naming the patient, the active ingredient, the dose and the treatment period, translated into Arabic and dated less than six months before travel, keep the quantity to a one month supply or the length of the stay, whichever is shorter, and declare it at customs; advance electronic clearance has been required since 1 November 2025. Loose tablets in a pill organiser are the shape of this problem that customs sees most often, so keep them in the dispensed box. The permit mechanics stated here are the SFDA traveller rules recorded on the current live cell and were not re-derived from the instrument in this pass. The Schedule II Category D placement was read in the 4 September 2026 schedules on 17 September 2026.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with Saudi Arabia’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.